Duchenne Muscular Dystrophy (DMD) Drugs Market Report
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Duchenne Muscular Dystrophy (DMD) Drugs Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-duchenne-muscular-dystrophy-dmd-drugs-market-3126
By Therapeutic Approach (Mutation Suppression, Exon Skipping, and Steroid Therapy), By Product Type (Corticosteroids and Pain Management Drugs), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); Company Market Share Analysis, End-User Landscape, and Competitor Analysis.
Key Market Insights
• The rising expenditures in biopharmaceutical research & development activities to launch new clinical treatments are driving the development of the Duchenne muscular dystrophy (DMD) treatment market.
• Corticosteroids are leading as per the product type because they aid in the maintenance of pulmonary and cardiovascular functionality during the non-ambulatory period of DMD.
• Mutation suppression is leading in the therapeutic approach segment because it addresses the underlying gene that causes muscular dystrophy.
• North America predominates the Duchenne muscular dystrophy market because of the increase in clinical trials for this field.
• Italfarmaco S.p.A., FibroGen, Inc., Summit Therapeutics Plc, PTC Therapeutics, Santhera Pharmaceuticals, Sarepta Therapeutics, Inc., NS Pharma, Inc., Wave Life Sciences, Daiichi Sankyo Company, Pfizer Inc., Solid Biosciences, amongst others, are the major players in the Duchenne muscular dystrophy (DMD) drugs market.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-duchenne-muscular-dystrophy-dmd-drugs-market-3126
Therapeutic Approach Type Outlook (Revenue, USD Billion, 2021-2026)
• Mutation Suppression
• Exon Skipping
• Steroid Therapy
Product Outlook (Revenue, USD Billion, 2021-2026)
• Pain management drugs
Regional Outlook (Revenue, USD Billion, 2021-2026)
• The U.S.
• Rest of Europe
• South Korea
• Rest of APAC
Central & South America
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• Rest of MEA
Contact: Yash Jain
Email address: firstname.lastname@example.org
Phone Number: +16026667238
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy (DMD) Drugs Market Report here
News-ID: 2285388 • Views: 434
More Releases from Global Market Estimates Research & Consultants
Global Virtual Reality Headset Market Size
According to a new market research report published by Global Market Estimates, the Global Virtual Reality Headset Market is expected to grow at a CAGR of 29.7% from 2023 to 2028. The virtual reality headset market is a dynamic and growing industry that offers a range of opportunities for players in various industries. As technology continues to advance and demand for immersive experiences increases, the market is expected to continue expanding
Global Trade Management Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global trade management market is expected to grow at a CAGR of 10.2%from 2023 to 2028. The major factors driving the growth of the global trade management market are increased investments in global logistics infrastructure, rising government regulations and compliances, increasing complexities in managing global trade, and strong international trade performance. The increased adoption of software solutions by
Global Cloud 5G Radio Access Network Market Size
According to a new market research report published by Global Market Estimates, the Global Cloud 5G Radio Access Network Market is projected to grow at a CAGR of 31.8% from 2023 to 2028. The rising demand for faster network connections, increasing dependability, and access to real-time data is creating opportunities for the existing and new emerging players, to enter the market with advanced network technologies. Browse 147 Market Data Tables and 115
Global Multi-Service Super Apps Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Multi-Service Super Apps Market is projected to grow at a CAGR of 23.9% from 2023 to 2028. Rising support from the government in order to help connect the vast population digitally, clubbed with increasing demand for an all-in-one service portal, and increasing adoption of smartphones and the growing availability of mobile internet are expected to support the
More Releases for Duchenne
Global Duchenne Muscular Dystrophy Market Research Report 2015-2025
About the Global Duchenne Muscular Dystrophy Market Research Report 2015-2025: Global Global Duchenne Muscular Dystrophy Market Research Report 2015-2025 2020 Research Report is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies
Global Duchenne Muscular Dystrophy Therapeutics Market Productions, Statistics 2 …
Qyresearchreports include new market research report "Global Duchenne Muscular Dystrophy Therapeutics Market Size, Status and Forecast 2022" to its huge collection of research reports. The general market for Duchenne Muscular Dystrophy Therapeutics has been analysed on various points of view that are practically present in the scenario, and have affected the market situation to the large extent. The report also presents exceptional experience and data identified with global Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Duchenne Muscular Dystrophy - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H2 2017, provides an overview of the Duchenne Muscular Dystrophy (Genetic Disorders) pipeline landscape. Duchenne muscular dystrophy is a condition which causes muscle weakness. DMD is an X-linked disorder.
Duchenne Muscular Dystrophy (DMD) Treatment Market - Global Industry Insights, T …
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin proterin, which is present the muscle. It is a rare muscle disease which majorly affects males. The symptoms includes intellectual disability, muscle weakness and, difficulty in walking and breathing. Congestive heart failure, mental impairment, pneumonia or respiratory failure are some of the
Duchenne Muscular Dystrophy (DMD) Market Forecast Research Reports Offers Key In …
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by muscle degeneration and weakness. Duchenne muscular dystrophy (DMD) cause due to lack of protein known as “dystrophin” which causes muscles deterioration and break down, leads to difficulty in walking and general mobility. DMD is a one of the most progressive childhood neuromuscular disorders. It affects mostly boys, but occasionally girls are affected. According to Muscular Dystrophy Australia, in 2016, Duchenne
Duchenne Muscular Dystrophy - Pipeline Review, H2 Pharmaceutical Research Report …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Duchenne Muscular Dystrophy - Pipeline Review, H2 2017”. Duchenne muscular dystrophy is a condition which causes muscle weakness. DMD is an X-linked disorder. The gene for DMD is present on the X chromosome. Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305512 It codes for a protein named dystrophin. Dystrophin is essential for providing structural support inside muscle cells.